These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1296358)
1. [The alimentary correction of dyslipoproteinemias in children with a hereditary risk for ischemic heart disease]. Peradze MB; Kvachadze IM; Uberi NP; Gus'kova VS Vopr Pitan; 1992; (5-6):22-5. PubMed ID: 1296358 [No Abstract] [Full Text] [Related]
2. [Clinico-biochemical validation of the use of PUFA omega-3 in patients with ischemic heart disease, familial hyperlipoproteinemias and hypertension]. Pogozheva AV; Samsonov MA; Levachev MM Vopr Pitan; 1996; (1):34-6. PubMed ID: 9157710 [TBL] [Abstract][Full Text] [Related]
3. [The mechanisms of the hereditary predisposition to ischemic heart disease]. Tseluĭko VI; Kantimir EV; Kostiurina GI; Bogmat LF Tsitol Genet; 1993; 27(4):77-81. PubMed ID: 8249169 [TBL] [Abstract][Full Text] [Related]
4. [Effect of antiatherosclerotic diet, containing polyunsaturated fatty acids of the omega-3 family from flax oil, on fatty acid composition of cell membranes of patients with ischemic heart disease. Hypertensive disease and hyperlipoproteinemia]. Rozanova IA; Pogozheva AV; Kupakova SN; Lupinovich VL; Karagodina ZV; Levachev MM; Samsonov MA Vopr Pitan; 1997; (5):15-7. PubMed ID: 9460845 [TBL] [Abstract][Full Text] [Related]
5. [The influence of diet with including amaranth oil on lipid metabolism in patients with ischemic heart disease and hyperlipoproteidemia]. Gonor KV; Pogozheva AV; Kulakova SN; Medvedev FA; Miroshnichenko LA Vopr Pitan; 2006; 75(3):17-21. PubMed ID: 16862949 [TBL] [Abstract][Full Text] [Related]
6. [Total and lipid-bound sialic acids in the blood in primary and secondary hyperlipoproteinemias]. Tvorogova MG; Rozhkova TA; Lupanov VP; Liakishev AA; Titov VN Ter Arkh; 1997; 69(1):23-5. PubMed ID: 9163043 [TBL] [Abstract][Full Text] [Related]
7. [The influence of a diet with including amaranth oil on antioxidant and immune status in patients with ischemic heart disease and hyperlipoproteidemia]. Gonor KV; Pogozheva AV; Derbeneva SA; Mal'tsev GIu; Trushina EN; Mustafina OK Vopr Pitan; 2006; 75(6):30-3. PubMed ID: 17313043 [TBL] [Abstract][Full Text] [Related]
8. [The study of influence of chitosan on clinical, metabolic and immune parameters in patients with cardiovascular diseases]. Pogozheva AV; Baĭgarin EK; Derbeneva SA; Varsanovich EA; Miagkova MA Vopr Pitan; 2005; 74(4):27-30. PubMed ID: 16265912 [TBL] [Abstract][Full Text] [Related]
9. [Effect of diet including omega-3 polyunsaturated fatty acids on the status of T-cell immunity in patients with ischemic heart disease and hyperproteinemia]. Sorokovoĭ KV; Pogozheva AV; Sergeeva KV Vopr Pitan; 1997; (5):6-8. PubMed ID: 9460842 [TBL] [Abstract][Full Text] [Related]
10. [Dyslipoproteinemias and the circadian variability of the lipid content of the blood in ischemic heart disease]. Seliverstova GP; Oranskiĭ IE Lab Delo; 1983; (1):14-7. PubMed ID: 6185723 [No Abstract] [Full Text] [Related]
11. [The effect of the dietary correction of nutrition on rehabilitative efficacy in IHD patients after having had a myocardial infarct during dispensary observation]. Shanavazova SA; Khasaev ASh Ter Arkh; 1996; 68(1):33-5. PubMed ID: 8644027 [TBL] [Abstract][Full Text] [Related]
12. [Clinical and metabolic effects of biological active food additives--phospholipids--in patients with cardiovascular diseases]. Samsonov MA; Vasil'ev AV; Pokrovskaia GR; Pogozheva AV; Moskvicheva IuB; Timofeenko TI; Kornena EP Vopr Pitan; 1997; (3):35-8. PubMed ID: 9289919 [TBL] [Abstract][Full Text] [Related]
13. [Disorders in the quantitative and qualitative composition of the serum lipoproteins in ischemic heart disease patients]. Orbetsov G; Orbetsova V; Dakovska L Vutr Boles; 1984; 23(5):100-6. PubMed ID: 6523839 [No Abstract] [Full Text] [Related]
14. [Effectiveness of nutritional correction in the prevention of ischemic heart disease]. Smoliar VI; Davidenko NV; Smirnova IP Gig Sanit; 1986 Apr; (4):8-12. PubMed ID: 3710223 [No Abstract] [Full Text] [Related]
15. [Plasma apoproteins and lipids in children and adolescents with hereditary susceptibility to ischemic heart disease]. Metel'skaia VA; Aĭngorn ED; Zholus NN; Perova NV; Belokon' NA Sov Med; 1986; (7):12-6. PubMed ID: 3764557 [No Abstract] [Full Text] [Related]
16. [Predicting effectiveness of omega-3 polyunsaturated fatty acid dietary treatment of patients with ischemic heart disease]. Endakova EA; Novgorodtseva TP; Kozycheva EV Vopr Pitan; 2000; 69(1-2):37-40. PubMed ID: 10943004 [TBL] [Abstract][Full Text] [Related]
17. Serum lipids and lipoprotein values in children of coronary artery disease parents. Mirza K; Ahmed P; Bilgrami N; Salahuddin A Indian Pediatr; 1984 Mar; 21(3):235-40. PubMed ID: 6490145 [No Abstract] [Full Text] [Related]
19. [Development of dyslipoproteinemias in 10- to 13-year-old schoolchildren (prospective epidemiological research)]. Dorofeeva TG; Tubol IB; Zhukovskiĭ GS; Perova NV; Ruzhanskaia TV Pediatriia; 1987; (3):11-5. PubMed ID: 3601531 [No Abstract] [Full Text] [Related]
20. [The effect of nutrition and other factors on the normalization and stabilization processes in dyslipoproteinemias]. Verbitskaia AI; Zhukovsakiĭ GS; Olfer'ev AM; Grishenkov EA Ter Arkh; 1990; 62(9):105-8. PubMed ID: 2281390 [No Abstract] [Full Text] [Related] [Next] [New Search]